Pay in 4 interest-free payments of $5.59 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
A clinical trial of sitagliptin in a small sample of patients with impaired glucose tolerance and mild T2DM found significant reductions in carotid intimal thickness in sitagliptin compared with diet control alone [122]
Chemical hybridization of glucagon and thyroid hormone optimizes therapeutic impact for metabolic disease
(Chief Medical Advisor, dual board-certified Obesity Medicine/Internal Medicine)
You are welcome to drop in at your convenience to ask questions and engage in discussion on the following topics: Biosimilars Dipeptidyl peptidase-4 (DPP-4) Inhibitors Glucagon-Like Peptide-1 (GLP-1) Agonists Additional Information and Resources Detailed information can also be found on our website at hpplans.com/formularies
Gutzwiller JP, Tschopp S, Bock A, et al
US$ 20.95
US$ 24.94
US$ 26.85
US$ 24.53
US$ 27.44
US$ 20.43
US$ 28.20
US$ 25.91
US$ 23.50
US$ 21.77
US$ 26.33
